Healthcare -
Biotechnology - NASDAQ - US
$ 8.91
0.955 %
$ 1.42 B
Market Cap
-7.62
P/E
OCUL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities OCUL - Ocular Therapeutix, Inc.
332 M
LAST VALUE
1411.33%
2 YEAR CAGR
34.54%
5 YEAR CAGR
15.45%
10 YEAR CAGR